Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases
Author added
Email me when SF 4189 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SF 4189. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill directs the state commissioner of health to conduct a comprehensive study of Minnesota’s capacity and strategies for cell and gene therapies that treat rare diseases. It requires a detailed report with recommendations to be delivered to the legislature by Jan. 1, 2028, and provides a one‑time appropriation for the work. The measure aims to inform policy, funding and regulatory actions that could improve access and economic development in this emerging field.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SF 4189
3 free questions a day, no accountHistory
- Author added Miller
- Author added Hemmingsen-Jaeger
- Author added Rasmusson
- Referred to Health and Human Services
- Introduction and first reading
Sponsors
- Coleman · sponsor
- Boldon
- Hemmingsen-Jaeger
- Miller
- Rasmusson
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SF 4189 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 4189 freeOr ask your AI assistant about SF 4189 directly:
Add to Claude, ChatGPT or Cursor